Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nupur Kikani

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Ophthalmology Clinics|March 20, 2021
Primer on Graves' Disease: What the Ophthalmologist Should Know and DoNupur Kikani, Ruchi Gaba
Endocrinology and Metabolism Clinics of North America|February 8, 2023
Remission in Ketosis-Prone DiabetesNupur Kikani, Ashok Balasubramanyam
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 30, 2024
Endocrinopathies Associated With Immune Checkpoint Inhibitor UseAnupam Kotwal, Randol Kennedy, Nupur Kikani, et al.
Expert Review of Endocrinology & Metabolism|November 27, 2025
The evolving management of endocrine disorders induced by checkpoint inhibitors: insights from the CIITED groupPriyanka C Iyer, Nupur Kikani, Sonya Khan, et al.
Expert Opinion on Drug Safety|April 17, 2026
Refractory immune-related adverse events (irAes) associated with immune checkpoint inhibitor therapy: a multiorgan management reviewMaria Julia Moura, Anirudha Chatterjee, Sharada Wali, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Ophthalmology Clinics|March 20, 2021
Primer on Graves' Disease: What the Ophthalmologist Should Know and DoNupur Kikani, Ruchi Gaba
Endocrinology and Metabolism Clinics of North America|February 8, 2023
Remission in Ketosis-Prone DiabetesNupur Kikani, Ashok Balasubramanyam
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 30, 2024
Endocrinopathies Associated With Immune Checkpoint Inhibitor UseAnupam Kotwal, Randol Kennedy, Nupur Kikani, et al.
Expert Review of Endocrinology & Metabolism|November 27, 2025
The evolving management of endocrine disorders induced by checkpoint inhibitors: insights from the CIITED groupPriyanka C Iyer, Nupur Kikani, Sonya Khan, et al.
Expert Opinion on Drug Safety|April 17, 2026
Refractory immune-related adverse events (irAes) associated with immune checkpoint inhibitor therapy: a multiorgan management reviewMaria Julia Moura, Anirudha Chatterjee, Sharada Wali, et al.
Pageof 1